Regeneron Pharmaceuticals (REGN) Q2 2017 Earnings

4MayConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
2.66
2.82
2.97
3.13

Details

Expected EPS
3.09
Actual EPS
2.92
Surprise EPS
-0.17
Surprise Percent
+5.5%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 2.92 per share for Q2 2017.

0 Comments

Share your thoughts